Explore how decentralized clinical trials (DCTs) are transforming clinical research in 2025 through technologies like telehealth, wearables, and digital platforms.
Read More
Discover how the FSP model enhances trial agility, oversight, and scalability, providing a strategic advantage in 2025 clinical development.
Explore the latest advancements in Huntington’s disease therapeutics—from gene silencing and small molecules to digital biomarkers.
Learn how emerging therapies and technologies from ARVO are transforming the landscape of ophthalmology research, and why strategic partners like TFS are key to advancing clinical success.
Explore ten standout biotech and specialty pharma companies driving innovation in the UK and Ireland.
Explore 10 emerging East Coast biotech companies driving innovation in 2025 across CNS, oncology, and dermatology clinical research.
Discover how TFS is advancing global clinical research with digital innovation, therapeutic expertise, and a flexible CRO model.
Discover how strategic resourcing empower biotech startups to navigate early clinical development challenges efficiently.
TFS shares key takeaways from ADPD 2025, highlighting scientific advancements in Parkinson’s disease research—and the power of partnership in bringing them to life.
Learn how real-time insights, analytics, and predictive modeling enhance efficiency, reduce risk, and accelerate time to market.
Learn how TFS is advancing sustainability in clinical research with innovative waste reduction initiatives in support of Zero Waste Day 2025!
Discover key takeaways from AAD 2025 and how emerging dermatology innovations are shaping clinical trials.
Explore how advancements in AI, teledermatology, and wearable sensors are revolutionizing dermatology clinical trials, enhancing efficiency, patient access, and data accuracy.
Discover how TFS HealthScience is revolutionizing neuroscience trials with AI, data-driven insights, and decentralized trials.
Explore how precision medicine is revolutionizing rare disease treatment through targeted therapies, gene editing, and AI-driven solutions.